Interactive Learning

0.50 CME Credit

Optimizing Acute Pain Care to Prevent Chronicity: Risk Assessment, Management, and Novel Nonopioid Therapy

Effective acute pain management is essential to improving patient outcomes and reducing the risk of chronic pain development. In this activity, expert faculty examine the clinical consequences of undertreated acute pain, identify risk factors that contribute to pain chronification, and review best practices for assessment and management using multimodal, opioid-sparing approaches. The program also highlights emerging evidence for a novel voltage-gated sodium channel (VGSC) inhibitor, including its mechanism of action, clinical efficacy and safety data, and potential role in contemporary acute pain management. Learners will leave better equipped to apply evidence-based strategies that optimize pain control while minimizing reliance on opioids.

Begin

CME Information

0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.50 AANP, including 0.33 AANP Pharm

Release Date: 6/19/2026

Expiration Date: 6/19/2027

Topics

Faculty

Steven Stanos, DO, FAAPMR

Learning Objectives

Identify the consequences of inadequately treated acute pain and risk factors that contribute to the transition from acute to chronic pain
Apply best practices for acute pain management, including the use of validated pain assessment tools, risk stratification, and multimodal, opioid-sparing therapeutic strategies
Describe the mechanism of action, clinical trial evidence, and appropriate use of the novel voltage-gated sodium channel (VGSC) inhibitor

Faculty

Steven Stanos, DO, FAAPMR

Clinical Instructor, UW Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA

Clinical Professor, Washington State University Elson S. Floyd, College of Medicine Spokane, Washington, Washington State University, Pullman, WA

Executive Medical Director, Rehabilitation & Performance Medicine, Swedish Medical Group, Medical Director, Swedish Medical Center, Seattle, WA

Learn More

Disclosures

The following relevant financial relationships have been disclosed by those in a position to influence the content of this activity. All relevant relationships have been mitigated by Pri-Med Institute:

Steven Stanos, MD: Consultant and Speaker for Averitas; Consultant for Collegium; Consultant and Speaker for Tonix; Consultant for Vertex; Consultant for Emergent.

All others in control of content for this activity have disclosed no relevant financial relationships.

CME Information

AMA PRA Category 1 Credits™

Accreditation Statement

Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP

Accreditation Statement

Pri-Med Institute is accredited by the American Association of Nurse Practitioners^® as an approved provider of nurse practitioner continuing education. Provider number: 040308.

Designation Statement

This activity is approved for 0.50 contact hour (which includes 0.33 hour of pharmacology).

MOC Credit Information

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points and Patient Safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Pri-Med Institute reports completion information to ACCME on a monthly basis, in the first week of each month.

Instructions for Obtaining Credit

After completing the activity, click the "Next" button to access a brief post-activity question and a downloadable resource. Once you have submitted your response, you will be directed to the claim credit screen to complete the credit claiming process. For PAs, the NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

Supported By

Vertex Pharmaceuticals Incorporated

Education Partner

Pri-Med Institute

Fine Print

Computer System Requirements

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

Disclaimer

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Statement of Independence

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Disclosure Policies and Contacting Pri-Med Institute

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.